// App-Quantinova.ai

e15637 : Impact of sorafenib treatment on portal hypertension in hepatocellular carcinoma patients.

Researchers

Presenter

  • Sahin Lacin

Principal Investigators

  • Reham Abdel-Wahab

  • Mohamed Elbanan

  • Shady Abdelbaki

  • Ahmed S Shalaby

  • Manal Hassan

  • Wei Wei

  • Jia Sun

  • Khaled M. Elsayes

  • Ahmed Omar Kaseb

Medical Centers

  • GI Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Clinical Oncology Department, Assiut University, Assiut, Egypt

  • Diagnostic Radiology Department, MD Anderson Cancer Center, Houston, TX

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • United States

  • Egypt

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Portal Hypertension

  • Hypertension

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Sorafenib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved